Intracutaneous injection
First Claim
1. A method for the administration of an injectable formulation into the epidermal, dermal or subcutaneous layer of an animal to effect pain-free or substantially pain-free administration of a therapeutic agent, comprising injecting from about 0.1 to about 10 microliters of an ultraconcentrated semisolid or solid formulation comprising from about 20 to about 85% solids by weight and comprising an effective amount of a therapeutic agent into the epidermal or dermal skin layer of an animal.
4 Assignments
0 Petitions
Accused Products
Abstract
The delivery of biopharmaceutical and other therapeutic agents parenterally to an animal via a minimally invasive, low pain administration is provided. The agents are delivered to the patient via, e.g., the epidermal, dermal, or subcutaneous layer of the skin in a concentrated form of injectable paste of slurry.
137 Citations
59 Claims
- 1. A method for the administration of an injectable formulation into the epidermal, dermal or subcutaneous layer of an animal to effect pain-free or substantially pain-free administration of a therapeutic agent, comprising injecting from about 0.1 to about 10 microliters of an ultraconcentrated semisolid or solid formulation comprising from about 20 to about 85% solids by weight and comprising an effective amount of a therapeutic agent into the epidermal or dermal skin layer of an animal.
- 19. An injectable formulation for intracutaneous administration comprising from about 0.1 to about 1000 microliters of an ultraconcentrated semisolid or solid formulation comprising an effective amount of a therapeutic agent homogeneously contained within a pharmaceutically acceptable carrier, said formulation comprising from about 20 to about 85% solids, by weight.
-
36. A device for injection of a therapeutic agent into the epidermal or dermal layer of the skin of an animal which effects pain-free or substantially pain-free administration of a therapeutic agent, comprising
a needle suitable for intradermal injection, said needle having a lower end containing a unit dose of a therapeutic agent homogeneously contained within a slurry or paste; - and a biasing device arranged at an upper end of said needle;
said needle and said biasing device being contained within a housing, said housing including an activator, such that when said injection device is set against the skin of an animal, said activator can be activated to release said biasing device, thereby causing said needle to penetrate the skin of an animal and forcing substantially all of said unit dose out of a tip located at the lower end of said needle. - View Dependent Claims (37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56)
- and a biasing device arranged at an upper end of said needle;
-
57. A method for the administration of an injectable formulation into the epidermal, dermal or subcutaneous layer of an animal to effect pain-free or substantially pain-free administration of a therapeutic agent, comprising incorporating from about 0.1 to about 10 microliters of an ultraconcentrated dry particulate formulation comprising an effective amount of a therapeutic agent and a pharmaceutically acceptable carrier into the needle of an injection device comprising a housing containing a needle suitable for intradermal injection, an actuator, and a biasing device;
- coating the inner surface of the needle with a suitable lubricant prior to incorporation of the formulation into the needle to allow particle flow of the formulation out of the needle in use;
positioning the housing against the skin of an animal, actuating the actuator such that the biasing device is released and causes the needle to penetrate the skin of an animal and forces the formulation out of the needle. - View Dependent Claims (58, 59)
- coating the inner surface of the needle with a suitable lubricant prior to incorporation of the formulation into the needle to allow particle flow of the formulation out of the needle in use;
Specification